Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bovie Medical Completes the Reacquisition of 2,000,0000 Convertible Preferred Shares; Anticipates Record Revenues for 1999.


Business Editors & Medical Writers

MELVILLE, N.Y.--(BUSINESS WIRE)--Jan. 6, 2000

Bovie Medical Corporation (the "Company") (OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system.
 Symbol: BOVI), a leading manufacturer and marketer of electrosurgical products, today announced that it has reacquired 2,000,000 convertible preferred shares Preferred shares

Preferred shares give investors a fixed dividend from the company's earnings and entitle them to be paid before common shareholders. See: Preferred stock.
 from Advanced Refractory refractory

Material that is not deformed or damaged by high temperatures, used to make crucibles, incinerators, insulation, and furnaces, particularly metallurgical furnaces.
 Technologies, Inc. (ART).

The Company reacquired the preferred shares from ART in exchange for the equipment, licensing and manufacturing rights to the DYLAN (DYnamic LANguage) An object-oriented programming language developed at Apple in the late 1980s with assistance from Harlequin Group plc, Carnegie Mellon University and others. Dylan was designed to provide the simplicity of Smalltalk with the efficiency of C++. (TM) technology previously granted by ART to the Company.

"We are very excited with the progress the Company has made over the last 30 days. The Company, in addition to the reacquisition of the two million convertible preferred shares, agreed to repurchase 2,000,000 of its common shares from a major shareholder group. To date, Bovie has repurchased approximately 1,120,000 of the shares and expects to purchase the remaining balance of 880,000 shares in the coming months. The transactions as already completed have reduced our current fully diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 shares outstanding from 17.1 million shares to 14.0 million shares," commented Andrew Makrides, president of Bovie Medical Corporation.

Mr. Makrides continued, "We are also very optimistic op·ti·mist  
n.
1. One who usually expects a favorable outcome.

2. A believer in philosophical optimism.



op
 about our business and anticipate reporting record revenues for 1999. With sound business prospects for the upcoming year and the reduction of our shares outstanding by almost one fourth, we are extremely confident about Bovie's future."

Bovie, through its wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
, Aaron Medical Industries, is engaged in the engineering, manufacturing and marketing of electrosurgical medical products.

This document may contain some forward looking statements, particularly regarding operational prospects in 1999 and beyond, which involve a number of risks an uncertainties tat could cause actual results to differ materially. These risks are listed from time to time in the Company's SEC filings.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 6, 2000
Words:290
Previous Article:Devine Entertainment's New Sales, E-Commerce & Marketing Projects Will Get $750,000 Support From Business Development Bank of Canada.
Next Article:Wilsons the Leather Experts Reports 17.7% Increase in December Sales.



Related Articles
Bovie Medical Reports Third Quarter Financial Results, Introduces New Products At International Medical Show.
Bovie Medical Reports Financial Results for 1999.
Bovie Medical Reports Record Second Quarter Results.
Bovie Medical Corp. Reports Nine Month Results: Receives Orders of $1.0 Million for New Electrosurgery Generators.
Bovie Medical Receives FDA 510/K Approval to Market New Electrosurgical Generator; Anticipates Record Revenues for 2000.
Bovie Medical Corporation Announces Record Second Quarter and Six Months Revenues: FDA Clearance to Market Electrosurgical Generator.
Bovie Medical Corporation Announces Record Second Quarter Revenues and a Dramatic Turnaround in Net Income.
Bovie Medical Corporation Reports Revenues and Net Earnings for Fiscal 2004.
Bovie Medical Corporation Reports Financial Results for Fiscal Year 2005.
Bovie Medical Corporation Reports Financial Results for First Quarter 2007.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles